Objective. The aim of this study was to evaluate the clinical relevance of the global APS
score (GAPSS) in a cohort of primary APS patients. Methods. This study included 62 …

Objective. To investigate the validity of the global APS score (GAPSS) to predict thrombosis
in patients with autoimmune diseases. Methods. This prospective cohort study included …

Objective Recently, our group conceived a risk score for clinical manifestations of APS (the
global APS score, or GAPSS) that takes into account the combination of independent …

Objective. To develop and validate a risk score [global APS score (GAPSS)] derived from the
combination of independent risk for thrombosis and pregnancy loss (PL), taking into account …

Objective The objective of this report is to independently validate the adjusted Global
Antiphospholipid Syndrome Score (aGAPSS) to predict thrombosis in a cohort of patients …

Objectives Extra-criteria manifestations of antiphospholipid syndrome (APS) might impact on
prognosis and morbidity of the disease. In this study, we aimed to evaluate a population of …

Objectives To assess whether patients with antiphospholipid syndrome (APS) and history of
recurrent thrombosis have higher levels of adjusted Global AntiphosPholipid Syndrome …

Objective To define the antiphospholipid score (aPL‐S) by testing multiple antiphospholipid
antibodies (aPL) and to evaluate its efficacy for the diagnosis of antiphospholipid syndrome …

Recently, we developed a risk score for antiphospholipid syndrome (APS)(Global APS
Score or GAPSS). This score derived from the combination of independent risk factors for …

Objective: To analyse antiphospholipid (aPL) antibody-positive patients using the 2006
revised antiphospholipid syndrome (APS) classification criteria. Methods: A descriptive study …